Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma

NCT00005951 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: irinotecan hydrochloride
DRUG: temozolomide

Sponsor

Duke University

Collaborators

[object Object]